Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • Spanish

Publications

  1. Ventricular Assist Device Use in Pediatric Restrictive and Hypertrophic Cardiomyopathy: An ACTION Registry Analysis. ASAIO J. 2025 May 21. View Abstract

  2. Donor History of Drug Use and Graft Survival in Pediatric Heart Transplant Recipients. JAMA Netw Open. 2025 Apr 01; 8(4):e257766. View Abstract

  3. Cardiac treatment for Duchenne muscular dystrophy: consensus recommendations from the ACTION muscular dystrophy committee. Cardiol Young. 2025 Apr; 35(4):770-775. View Abstract

  4. Taking ACTION to detect myocarditis related to recombinant gene transfer therapy for Duchenne Muscular Dystrophy; Consensus recommendations for cardiac surveillance. J Neuromuscul Dis. 2025 Mar; 12(2):173-182. View Abstract

  5. Real-World Use and Outcomes of Apixaban for Early Post-Surgical Fontan Thromboprophylaxis. Pediatr Cardiol. 2024 Sep 12. View Abstract

  6. Improving Mechanical Circulatory Support Outcomes in Failing Bidirectional Glenn Physiology. Pediatr Cardiol. 2024 Jul 19. View Abstract

  7. Impact of a positive crossmatch on pediatric heart transplant outcomes. J Heart Lung Transplant. 2024 Jun; 43(6):963-972. View Abstract

  8. Contemporary Outcomes of Children With Acute Fulminant Myocarditis Supported With Peripheral Extracorporeal Membrane Oxygenation. ASAIO J. 2024 04 01; 70(4):321-327. View Abstract

  9. Use of apixaban in children awaiting heart transplantation. Pediatr Transplant. 2024 02; 28(1):e14632. View Abstract

  10. Contemporary outcomes of pediatric cardiac transplantation with a positive retrospective crossmatch. Pediatr Transplant. 2023 Nov; 27(7):e14593. View Abstract

  11. Nucleated Red Blood Cells Are Predictive of In-Hospital Mortality for Pediatric Patients. Pediatr Emerg Care. 2023 Dec 01; 39(12):907-912. View Abstract

  12. Real-world use of apixaban for the treatment and prevention of thrombosis in children with cardiac disease. J Thromb Haemost. 2023 06; 21(6):1601-1609. View Abstract

  13. Apixaban Anticoagulation in Children and Young Adults Supported With the HeartMate 3 Ventricular Assist Device. ASAIO J. 2023 06 01; 69(6):e267-e269. View Abstract

  14. Initial multicenter experience with ventricular assist devices in children and young adults with muscular dystrophy: An ACTION registry analysis. J Heart Lung Transplant. 2023 02; 42(2):246-254. View Abstract

  15. The Surprise Question as a Trigger for Primary Palliative Care Interventions for Children with Advanced Heart Disease. Pediatr Cardiol. 2022 Dec; 43(8):1822-1831. View Abstract

  16. Pneumatosis intestinalis after thoracic organ transplantation in children: A case series and review of the literature. Clin Transplant. 2022 06; 36(6):e14654. View Abstract

  17. Pediatric heart transplant waiting times in the United States since the 2016 allocation policy change. Am J Transplant. 2022 03; 22(3):833-842. View Abstract

  18. Current Practices in Treating Cardiomyopathy and Heart Failure in Duchenne Muscular Dystrophy (DMD): Understanding Care Practices in Order to Optimize DMD Heart Failure Through ACTION. Pediatr Cardiol. 2022 Jun; 43(5):977-985. View Abstract

  19. Coagulation profiles and viscoelastic testing in multisystem inflammatory syndrome in children. Pediatr Blood Cancer. 2021 12; 68(12):e29355. View Abstract

  20. Rehabilitation in Pediatric Heart Failure and Heart Transplant. Front Pediatr. 2021; 9:674156. View Abstract

  21. The epigenetic modifier ubiquitin-specific protease 22 (USP22) regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2 (SOX2). J Biol Chem. 2013 Aug 16; 288(33):24234-46. View Abstract

  22. Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. J Mol Cell Cardiol. 2013 Jul; 60:97-106. View Abstract

  23. The use of human embryonic stem cells in drug discovery. Counterpoint. Clin Pharmacol Ther. 2011 May; 89(5):641-3. View Abstract

  24. Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts. PLoS One. 2010 Jul 12; 5(7):e11536. View Abstract

  25. Correction of moderate myopia is associated with improvement in self-reported visual functioning among Mexican school-aged children. Invest Ophthalmol Vis Sci. 2007 Nov; 48(11):4949-54. View Abstract

  26. The association between refractive cutoffs for spectacle provision and visual improvement among school-aged children in South Africa. Br J Ophthalmol. 2008 Jan; 92(1):13-8. View Abstract

  27. Factors associated with spectacle-wear compliance in school-aged Mexican children. Invest Ophthalmol Vis Sci. 2006 Mar; 47(3):925-8. View Abstract
BESbswy